News for Healthier Living

High BMI eligibility for semaglutide could cost Medicare an additional $145 billion annually

A brief research report found that 61% of Medicare-eligible adults have a BMI of 27 or higher, which means they may benefit from a GLP-1 receptor agonist like semaglutide for weight loss.

August 26, 2024


September 15 2024

September 14 2024

September 13 2024

September 12 2024

September 11 2024

September 10 2024

September 9 2024

September 8 2024

September 7 2024

September 6 2024

September 5 2024

September 4 2024

September 3 2024

September 2 2024